Clinical pharmacological studies with haloperidol.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001714:Bipolar Disorder / Q000188:drug therapy*; D001769:Blood; D002389:Catatonia / Q000188:drug therapy*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced; D010259:Paranoid Disorders / Q000188:drug therapy*; D010276:Parasympatholytics / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*
D010276:Parasympatholytics; D006220:Haloperidol